A Phase 1, Open-Label, Sequential Cross-over, Bioavailability/Bioequivalence Study to Compare the Pharmacokinetics of Oral Cladribine With the Reference Listed Drug, Intravenous Cladribine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
University of Rochester
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Northwestern University
University Hospital Muenster
Swiss Cancer Institute
Swiss Cancer Institute